ABSTRACT
This article explores common organizational pressure points for ‘Five Eyes’ intelligence communities in their ability to understand, prevent and disrupt potential emerging bio-threats and risks. The acceleration in the development of synthetic biology and biotechnology for legitimate markets (e.g. pharmaceuticals, food production and energy) is moving faster than current intelligence communities’ ability to identify and understand potential bio-threats and risks.
The article surveys several political leadership and intelligence governance challenges responsible for the current sub-optimal development of health security intelligence capabilities and identifies possible policy suggestions to ameliorate challenges.
